Mefloquine shortage

Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) continues
Mefloquine shortage
  • This updates the news item of 6 May 2026

Neon Healthcare have advised NaTHNaC that 250mg mefloquine (Lariam) antimalarial tablets are currently out of stock in the UK. A delivery is expected between July and September 2026.

Advice for health professionals

Clinics and pharmacies with remaining supplies of mefloquine should prioritise travellers with imminent travel for whom mefloquine is the first choice of antimalarial. This includes pregnant travellers visiting high risk malaria regions such as Sub-Saharan Africa.

Travellers who can take alternative antimalarials should be prescribed these, in order to preserve mefloquine supplies for those who cannot use other options.

Country specific advice about malaria risks and antimalarial recommendations available from the TravelHealthPro Country Information pages.

The UK Malaria Expert Advisory Group (UKMEAG) Malaria prevention guidelines for travellers from the UK provide detailed malaria advice and guidance for health professionals advising travellers and are the first port of call for queries.

Alternative suppliers

The following specialist importers have confirmed they can source unlicensed mefloquine 250 mg tablets (please note there may be other companies that can also source supplies):

  • Alium
  • Chemys
  • Genetech
  • Smartway
  • Target Healthcare

Any decision to prescribe an unlicensed medicine must consider the relevant guidance and NHS Trust or local governance procedures. Unlicensed imports do not undergo any central quality assessment or suitability evaluation. Therefore, any import must be locally assessed in line with local unlicensed medicines processes. Please see the resources section below for further information.

If attempts to source mefloquine for an individual traveller are not successful, health professionals can contact NaTHNaC's telephone advice line for further advice.

The UK Health Security Agency Malaria Reference Laboratory offers an email advisory service for health professionals for complex queries which cannot be answered after consulting the Malaria prevention guidelines for travellers from the UK.

  1. Mefloquine shortage continues; supplies expected to resume between July and September 2026.

  2. Shortage expected until the end of May 2026.

  3. Shortage expected until the end of April 2026.

  4. Shortage expected until the end of March 2026.

  5. Alternative suppliers and additional references added.


Search by


Explore more

Hajj 1447H: 2026

Information for pilgrims performing Hajj in 2026

Updated: 17 June 2026

Hantavirus cruise ship outbreak

WHO and UKHSA are monitoring a hantavirus outbreak linked to a cruise ship, with the risk to the UK public currently assessed as very low

Updated: 12 June 2026

Survey study for travellers and healthcare professionals on rabies risk

Please help us to learn more about knowledge, attitudes, and practices regarding rabies risk

Updated: 11 June 2026

Country Information updates: Measles

NaTHNaC has reviewed the measles risk for travellers and updated TravelHealthPro country-specific information pages with new measles guidance

Updated: 26 May 2026